[GLP-1 agonists reduce the risk of major cardiovascular events in older patients with type 2 diabetes, and SGLT2 inhibitors prevent hospitalizations for acute heart failure]
Recenti Prog Med
.
2024 Dec;115(12):604-605.
doi: 10.1701/4392.43920.
[Article in Italian]
Authors
Viviana Forte
1
,
Henry Barry
2
,
Peter K Kurotschka
3
Affiliations
1
Dipartimento di Scienze mediche e sanità pubblica, Università di Cagliari, Italia.
2
Department of Family medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan, Usa.
3
Department of General practice, University Hospital Würzburg, Germany.
PMID:
39688044
DOI:
10.1701/4392.43920
No abstract available